Modulation of angiotensin II receptor expression during development and regression of hypoxic pulmonary hypertension

被引:60
作者
Chassagne, C
Eddahibi, S
Adamy, C
Rideau, D
Marotte, F
Dubois-Randé, JL
Adnot, S
Samuel, JL
Teiger, E
机构
[1] Univ Denis Diderot, Hop Lariboisiere, INSERM,U127, Inst Federatif Rech Circulat, F-75010 Paris, France
[2] Hop Henri Mondor, INSERM, U400, Inst Mol Med, F-94010 Creteil, France
[3] Hop Henri Mondor, INSERM, U492, Inst Mol Med, F-94010 Creteil, France
关键词
D O I
10.1165/ajrcmb.22.3.3701
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lung vessel muscularization during hypoxic pulmonary hypertension is associated with local renin-angiotensin system activation. The expression of angiotensin II (Ang II) AT1 and AT2 receptors in this setting is not well known and has never been investigated during normoxia recovery. We determined both chronic hypoxia and normoxia recovery patterns of AT1 and AT2 expression and distal muscularization in the same lungs using in situ binding, reverse transcriptase/polymerase chain reaction, and histology. We also used an isolated perfused lung system to evaluate the vasotonic effects of AT1 and AT2 during chronic exposure to hypoxia with and without subsequent normoxia recovery. Hypoxia produced right ventricular hypertrophy of about 100% after 3 wk, which reversed with normoxia recovery. Hypoxia for 2 wk was associated with simultaneous increases (P < 0.05) in AT1 and AT2 binding (16-fold and 18-fold, respectively) and in muscularized vessels in alveolar ducts (2.8-fold) and walls (3.7-fold). An increase in AT2 messenger RNA (mRNA) (P < 0.05) was also observed, whereas AT1 mRNA remained unchanged. After 3 wk of hypoxia, muscularization was at its peak, whereas all receptors and transcripts showed decreases (P < 0.05 versus hypoxia 2 wk for AT1 mRNA), which became significant after 1 wk of normoxia recovery (P < 0.05 versus hypoxia 2 wk). Significant reversal of muscularization (P < 0.01) was found only after 3 wk of normoxia recovery in alveolar wall vessels. Finally, the AT1 antagonist losartan completely inhibited the vasopressor effect of Ang II in hypoxic and normoxia-restored lungs, whereas the AT2 agonist CGP42112A had no effect. Our data indicate that in lungs, chronic hypoxia-induced distal muscularization is associated with early and transient increases in AT2 and AT1 receptors probably owing to hypoxia-dependent transcriptional and post-transcriptional regulatory mechanisms, respectively. They also indicate that the vasotonic response to Ang II is mainly due to the AT1 subtype.
引用
收藏
页码:323 / 332
页数:10
相关论文
共 50 条
  • [1] LOSS OF ENDOTHELIUM-DEPENDENT RELAXANT ACTIVITY IN THE PULMONARY CIRCULATION OF RATS EXPOSED TO CHRONIC HYPOXIA
    ADNOT, S
    RAFFESTIN, B
    EDDAHIBI, S
    BRAQUET, P
    CHABRIER, PE
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (01) : 155 - 162
  • [2] Possible role of P-450 metabolite of arachidonic acid in vasodilator mechanism of angiotensin II type 2 receptor in the isolated microperfused rabbit afferent arteriole
    Arima, S
    Endo, Y
    Yaoita, H
    Omata, K
    Ogawa, S
    Tsunoda, K
    Abe, M
    Takeuchi, K
    Abe, K
    Ito, S
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (11) : 2816 - 2823
  • [3] Role of type 1 and type 2 angiotensin receptors in angiotensin II-induced cardiomyocyte hypertrophy
    Booz, GW
    Baker, KM
    [J]. HYPERTENSION, 1996, 28 (04) : 635 - 640
  • [4] CHIU AT, 1993, CELLULAR MOL BIOL RE, P245
  • [5] SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION
    CHOMCZYNSKI, P
    SACCHI, N
    [J]. ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) : 156 - 159
  • [6] Ciafre Silvia Anna, 1993, Recenti Progressi in Medicina, V84, P248
  • [7] CLOZEL JP, 1991, J CARDIOVASC PHARM, V17, P36, DOI 10.1097/00005344-199101000-00006
  • [8] DURMOWICZ AG, 1994, AM J PATHOL, V145, P1411
  • [9] DILATOR EFFECT OF ENDOTHELINS IN PULMONARY CIRCULATION - CHANGES ASSOCIATED WITH CHRONIC HYPOXIA
    EDDAHIBI, S
    SPRINGALL, D
    MANNAN, M
    CARVILLE, C
    CHABRIER, PE
    LEVAME, M
    RAFFESTIN, B
    POLAK, J
    ADNOT, S
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 265 (06): : L571 - L580
  • [10] PROTECTION FROM PULMONARY-HYPERTENSION WITH AN ORALLY-ACTIVE ENDOTHELIN RECEPTOR ANTAGONIST IN HYPOXIC RATS
    EDDAHIBI, S
    RAFFESTIN, B
    CLOZEL, M
    LEVAME, M
    ADNOT, S
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1995, 268 (02): : H828 - H835